Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 28, 2021 at 12:16 pm
Share
Guizhou Xinbang Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 4,723.07 million compared to CNY 4,279.54 million a year ago. Revenue was CNY 4,723.07 million compared to CNY 4,279.54 million a year ago. Net income was CNY 210.08 million compared to CNY 123.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.12 compared to CNY 0.08 a year ago. Diluted earnings per share from continuing operations was CNY 0.12 compared to CNY 0.08 a year ago.
GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.